SUBSTITUIERTE XANTHINDERIVATE

Patent europeic · EP2473053 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2473053
Numer da la dumonda
EP10814504
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
02-09-2010
Publitgà
11-07-2012
Concedì
22-04-2015
Stritgà
30-09-2016
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 473/04 (2006.01)
A61K 31/522 (2006.01)
A61P 13/12 (2006.01)
Prioritad
US 239342 P 02.09.2009
US 873991 01.09.2010
Dumonda PCT
PCT/US2010/047708 02.09.2010
Publicaziun PCT
WO2011/028922 10.03.2011
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 19-04-2017

    Stritgà, taxa betg pajada

    Published in Swissreg on 19.04.2017

  2. 22-04-2015

    Concedì

    Published in Swissreg on 22.04.2015

Partidas

Possessur

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals Inc.

99 Hayden Avenue, Suite 500, Lexington, MA 02421, US

Inventur

TUNG, Roger D.

Lexington Massachusetts 02420, US

LIU, Julie F.

Lexington Massachusetts 02420, US

HARBESON, Scott L.

Cambridge Massachusetts 02140, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.